Savant Capital’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$155K Sell
41,987
-10,288
-20% -$54.1K ﹤0.01% 2251
2026
Q2
$327K Buy
52,275
+36,324
+228% +$241K ﹤0.01% 1445
2026
Q1
$116K Buy
15,951
+3,000
+23% +$39.1K ﹤0.01% 1460
2025
Q4
$220K Buy
+12,951
New +$132K ﹤0.01% 1240

Other funds holding WVE

Savant Capital's WVE Position: Q3 2026 in Review

Savant Capital reduced its Wave Life Sciences (WVE) stake by 20% in Q3 2026, selling an estimated $54.1K and leaving 41,987 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #2251.

Savant Capital first reported a position in WVE in Q4 2025 and has held it in 4 quarters since. The position peaked at $327K in Q2 2026. 211 funds tracked by Wall St. Rank hold WVE as of Q3 2026.

  • Savant Capital held 41,987 shares of Wave Life Sciences worth $155K as of Q3 2026.
  • Savant Capital sold 10,288 Wave Life Sciences shares in Q3 2026, an estimated $54.1K.
  • Wave Life Sciences made up ﹤0.01% of Savant Capital's portfolio in Q3 2026, its #2251 holding.
  • Savant Capital first reported a position in Wave Life Sciences in Q4 2025 and has held it in 4 quarters since.
  • Savant Capital's Wave Life Sciences position peaked at $327K in Q2 2026.
  • 211 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2026.

Based on Savant Capital's 13F filing for Q3 2026, filed 6 Nov 2026.